OHTA Mitsuhiro | Department of Applied Chemistry, Muroran Institute of Technology
スポンサーリンク
概要
関連著者
-
OHTA Mitsuhiro
Department of Applied Chemistry, Muroran Institute of Technology
-
Yoshida Yutaka
Department of Structural Pathology Institute of Nephrology, Graduate School of Medical and Dental Sc
-
SUSSMAN Mark
Department of Mathematics, Florida State University
-
Ohta Mitsuhiro
Clinical Chemistry Laboratory Kobe Pharmaceutical University
-
Sussman Mark
Department Of Mathematics Florida State University
-
Yoshida Yutaka
Departmanets Of Structural Pathology Institute Of Nephrology Graduate School Of Medical And Dental S
-
Ohta Mitsuhiro
Division of Applied Sciences, Graduate School of Engineering, Muroran Institute of Technology
-
Yoshida Yutaka
Division Of Applied Sciences Graduate School Of Engineering Muroran Institute Of Technology
-
Ohta Mitsuhiro
Division Of Applied Sciences Graduate School Of Engineering Muroran Institute Of Technology
-
Yoshida Yutaka
Deparlment Of Internal Medicine School Of Medicine Kobe University
著作論文
- Direct Numerical Simulation of the Slow Formation Process of Single Bubbles in a Viscous Liquid
- Risk Factors for Heatstroke among Japanese Forestry Workers
- The Effect of Heavy Metals on Nicotinamide N-methyltransferase Activity In Vitro Relating to Parkinson's Disease
- Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease
- Normal Growth after Administration of Octreotide: Report on a Case of Persistent Hyperinsulinemic hypoglycemia of infancy Treated by Continuous Subcutaneous Injection of Octreotide
- Three-Dimensional Computations of the Motion of a Newtonian Drop Rising through Immiscible Quiescent Shear-Thinning Liquids
- Three-Dimensional Numerical Simulations of the Effect of Initial Bubble Conditions on the Motion of a Bubble Rising in Viscous Liquids
- Three-Dimensional Numerical Simulations of the Motion of a Gas Bubble Rising in Viscous Liquids
- Enzyme-linked immunosorbent assay of nicotine metabolites
- Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease